Adipocytes impact on gastric cancer progression: Prognostic insights and molecular features

Table 2 The validation group included clinical and pathological features of gastric cancer patients, n = 425, n (%)

Clinical characteristics	Adipose infiltration			P value
	Negative, n = 364	Positive, n = 61	Overall, n = 425
Age in yr				0.138
> 60	223 (61.30)	44 (72.10)	267 (62.80)
≤ 60	141 (38.70)	17 (27.9)	158 (37.20)
Sex
Male	257 (70.60)	47 (77.00)	304 (71.50)
Female	107 (29.40)	14 (23.00)	121 (28.50)
Perineural invasion				1.000
No	295 (81.00)	49 (80.30)	344 (80.90)
Yes	69 (19.00)	12 (19.70)	81 (19.10)
Vascular invasion				0.396
No	284 (78.00)	44 (72.10)	328 (77.20)
Yes	80 (22.00)	17 (27.90)	97 (22.80)
M stage				0.012
M0	355 (97.50)	55 (90.20)	410 (96.50)
M1	9 (2.50)	6 (9.80)	15 (3.50)
T stage				0.238
T1	206 (56.60)	43 (70.50)	249 (58.60)
T2	85 (23.40)	10 (16.40)	95 (22.40)
T3	65 (17.90)	8 (13.10)	73 (17.20)
T4	8 (2.20)	0 (0.00)	8 (1.90)
N stage				0.444
N0	251 (69.00)	36 (59.00)	287 (67.50)
N1	35 (9.60)	7 (11.50)	42 (9.90)
N2	39 (10.70)	10 (16.40)	49 (11.50)
N3	39 (10.70)	8 (13.10)	47 (11.10)